Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
TWO and CrossCountry Mortgage, LLC Announce Amended Merger Agreement Increasing All-Cash Consideration to $12.00 Per Share
-
Oshkosh Corporation Reports 2026 First Quarter Results
-
AT&T to Webcast Fireside Chat with John Stankey at the 2026 J.P. Morgan Global Technology, Media and Communications Conference on May 19
-
Herbalife and Cristiano Ronaldo Bring Performance Nutrition to Everyday Routines with “Fuel Like Ronaldo” Campaign
-
First Advantage to Participate in Upcoming Investor Conferences
-
Qrypt CTO Denis Mandich to Discuss Quantum-Safe Networking for AI Infrastructure at ONUG AI Networking Summit
-
Black Diamond Group Limited Announces Renewal of Normal Course Issuer Bid
-
1stDibs Reports First Quarter 2026 Financial Results
-
Telephone and Data Systems Announces Proposal to Acquire Public Shares of Array Digital Infrastructure
-
CYNREN Launches Next Generation Advisory Firm Serving Family Offices, Funds and Institutions
-
NHC Reports First Quarter 2026 Earnings
-
Sagtec Global Limited Strengthens Smart Property Development Collaboration Following Stateight Sdn Bhd’s Industry Recognition
-
Essential Utilities Marks Drinking Water Week 2026 With Record Infrastructure Investment, Industry-Leading Compliance
-
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
-
Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years
-
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
-
Dollar General Literacy Foundation Celebrates Another One-Day Grant Milestone
-
Form 8.3 Picton Property Income Limited
-
Form 8.3 LondonMetric Property Plc & Schroder REIT Limited
-
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
Form 8.3 Bluefield Solar Income Fund Ltd.
-
Ur-Energy Reports Q1 2026 Results and Announces Conference Call and Webcast
-
EMBRAER EARNINGS RELEASE 1Q26
-
TELUS Corporation - NOTICE OF CASH DIVIDEND
-
RE/MAX HOLDINGS, INC. REPORTS FIRST QUARTER 2026 RESULTS
-
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
-
TELUS Announces Retirement of Chief Financial Officer Doug French and Appointment of Successor Gopi Chande
-
Form 8.3 Advanced Medical Solutions Group
-
Brookfield Business Corporation Reports Strong First Quarter 2026 Results
-
TELUS reports operational and financial results for first quarter 2026
-
Brookfield Asset Management Announces Strong First Quarter Results
-
Castellum Announces First Quarter 2026 Financial Results
-
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
-
One Year into MoCRA: CosmeticSafetyRecord.com Publishes 10-Answer Library
-
Kvika banki hf.: Shareholders’ Meeting Announcement
-
Leveraging the Legacy of the 2025 Osaka Expo — SkyDrive and Partners Launch Japan’s First Consortium for Vertiport Operations —
-
XCF Global Highlights Strategic Role of Renewable Fuels in Strengthening U.S. Energy Security
-
Trans Canada Gold Completes Second Tranche of the Non-Brokered Private Placement and Prepares for Drilling at the Harrison Lake Gold Project
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Man Group PLC : Form 8.3 - JTC Plc
-
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
Essent Group Ltd. Announces First Quarter 2026 Results and Declares Quarterly Dividend
-
Algonquin Power & Utilities Corp. Reports First Quarter 2026 Financial Results
-
AdvanSix Announces First Quarter 2026 Financial Results
-
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil
-
Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives
-
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results
-
Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026
-
Westwater Resources Announces First Quarter 2026 Business Update Webcast
-
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology

